Kovina Therapeutics

Private

Indianapolis, IndianaHealthcare & Life Scienceshttps://www.kovina.com/

Last Round

Grant

Nov 2, 2022

Total Funding Raised

$4.98M

Company Overview

Kovina Therapeutics is a biotechnology company developing first-in-class small molecule antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

biotechnologysmall-molecule drugsHPV inhibitorsoncologydrug discoveryhuman papillomavirusHPVpreclinical researchantiviral therapyE6 oncoproteinE7 oncoproteinbiotech startuptherapeutic developmentinfectious diseasedrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kovina Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Kovina Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kovina Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 2, 2022
Grant	Sep 13, 2022
Grant	Jun 18, 2022
Seed	Oct 20, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Kristin Sherman

Chief Executive Officer

Executive Team

Kovina Therapeutics Investors

Notable investors and investment history

Kovina Therapeutics investors
Investor	Rounds
National Cancer Institute	Grant
National Institute of Allergy and Infectious Diseases	Grant
Elevate Ventures	Seed
BioCrossroads	Seed
IU Ventures	Seed
National Institute of Dental and Craniofacial Research	Grant
National Institutes of Health (NIH)	Grant

View all Investors

Kovina Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kovina Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kovina Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIndianapolis, Indiana

Employee Range5

Year Founded2020

Last FundingNov 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.